Amneal Pharmaceuticals, Inc. AMRX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s free cash flow?
- Amneal Pharmaceuticals, Inc. (AMRX) reported free cash flow of -$34.92M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s free cash flow changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s free cash flow decreased by 506.8% year-over-year, from -$5.75M to -$34.92M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s free cash flow?
- Over 2 years (2023 to 2025), Amneal Pharmaceuticals, Inc.'s free cash flow has grown at a -9.0% compound annual growth rate (CAGR), from $325.71M to $269.93M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.